Compare IMA & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMA | HNNA |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2M | 76.4M |
| IPO Year | N/A | N/A |
| Metric | IMA | HNNA |
|---|---|---|
| Price | $6.49 | $10.32 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 50.1K | 8.9K |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | N/A | ★ 5.50% |
| EPS Growth | N/A | ★ 38.04 |
| EPS | N/A | ★ 1.27 |
| Revenue | $800,000.00 | ★ $35,538,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.87 |
| Revenue Growth | N/A | ★ 19.88 |
| 52 Week Low | $6.19 | $8.43 |
| 52 Week High | $18.00 | $13.88 |
| Indicator | IMA | HNNA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.88 |
| Support Level | N/A | $9.33 |
| Resistance Level | N/A | $10.39 |
| Average True Range (ATR) | 0.00 | 0.32 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 61.47 |
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.